"La Clinique de l'Europe est un établissement de santé pluridisciplinaire situé à Amiens, dans les Hauts-de-France. Elle fait partie du Groupe Vivalto Santé, troisième acteur national de l'hospitalisation privée."

During the past decade, Clinique de L'Europe conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 6 clinical trials were completed, i.e. on average, 20.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique de L'Europe" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 9 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "UNICANCER" with 5 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 4 trials sponsored and "Centre Hospitalier Universitaire, Amiens" with 4 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique de L'Europe" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Centre Henri Becquerel" with 1 trials as a collaborator and "Centre Hospitalier Universitaire Dijon" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Clinique de L'Europe" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "Metastatic Colorectal Cancer" (3 trials), "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials) and "Gastric Adenocarcinoma" (2 trials). Many other conditions were trialed in "Clinique de L'Europe" in a lesser frequency.

Most popular intervention types in "Clinique de L'Europe" are "Drug" (27 trials), "Device" (4 trials), "Radiation" (4 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Chemotherapy" (3 trials), "Atezolizumab" (2 trials), "Cetuximab" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinique de L'Europe" are 34 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique de L'Europe". undefined are not yet recruiting, 11 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Clinique de L'Europe, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique de L'Europe, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".